https://www.selleckchem.com/pr....oducts/bms-265246.ht
5%. Among patients treated with oral bisphosphonates (BPs), 83.3% were effectively treated with teriparatide and 40% with intravenous BPs. The oral administration of BPs was associated with successful treatment outcomes with teriparatide (p = 0.062). CONCLUSIONS Teriparatide therapy has potential as an effective treatment option for MRONJ. BACKGROUND Condoliase is a novel, potent chemonucleolytic drug available for clinical use for lumbar disc herniation (LDH) in Japan. The aim of this study was to assess the clinical outcome of cond
Like
Comment
Share
